When psoriasis is extensive, disabling, or attacking the joints, treating it from the outside stops being enough. These are the drugs that work from the inside — powerful, well-evidenced, and requiring proper monitoring.
Systemic treatment is considered when disease is extensive, when it has failed adequate topical and phototherapy trials, when it is disabling out of proportion to its area — palms and soles are the classic example — or when there is psoriatic arthritis, because joints do not respond to anything applied to skin.
That last point deserves emphasis. Joint damage in psoriatic arthritis is irreversible, and the window in which treatment prevents it is early. A patient with joint symptoms is not someone to try another cream on.
The trade is real and it is discussed openly: these drugs suppress immune function and require monitoring. For the right patient the balance is strongly favourable. For someone with mild, limited disease it is not, and the honest answer is to stay on the lower rungs.
| Drug | Suits | Requires |
|---|---|---|
| Methotrexate | Extensive disease; also treats psoriatic arthritis | Regular blood counts and liver monitoring; no alcohol excess; not in pregnancy |
| Ciclosporin | Rapid control of a severe flare; short-term use | Blood pressure and kidney monitoring; time-limited courses |
| Acitretin | Palmoplantar and pustular disease | Lipid and liver monitoring; strict pregnancy avoidance for years after |
| Apremilast | Moderate disease where monitoring is difficult | No routine blood monitoring; nausea and weight loss common early |
Choice depends on your other conditions as much as on the psoriasis — liver, kidneys, blood pressure, alcohol use and pregnancy plans all narrow the list before anything else is considered.
Biologics are injected antibodies that block a single specific inflammatory messenger driving psoriasis, rather than suppressing immune function broadly.
Latent tuberculosis and hepatitis B and C are screened for before any biologic is started. In India, TB screening is not a formality.
The main barrier in India is cost, and biosimilars have changed but not removed it. This is discussed frankly before starting.
Every systemic drug here has a monitoring schedule, and the schedule exists because the problems it catches are silent until they are not. Methotrexate can affect blood counts and the liver without any symptom at all until damage is done.
So treatment is not started unless the monitoring is realistic for you — which for patients outside Hyderabad means agreeing where blood tests will be done locally and how results will reach the clinic.
Arrange a systemic-therapy reviewBloods, and screening where a biologic is planned. Nothing starts before the baseline is in hand.
Out-of-state patients have bloods done locally and reviewed by video. It works, provided it is agreed in advance.
When disease is extensive, has failed adequate topical and phototherapy treatment, or when psoriatic arthritis is present — methotrexate treats both skin and joints, which phototherapy does not.
It requires respect rather than fear. Regular blood monitoring catches the problems that matter, alcohol must be limited, and it is absolutely avoided in pregnancy. Within those boundaries it has decades of safe use in psoriasis.
Yes, including biosimilars which have reduced cost substantially. Cost remains the main barrier for most patients, and it is discussed openly before starting rather than after.
Biologics can reactivate latent tuberculosis. Given TB prevalence in India, screening before starting is essential and is not optional.
Sometimes, with a planned reduction. Psoriasis usually returns after stopping, so the decision balances how long remission has held against the burden of continuing. It is never stopped abruptly.
Several are absolutely contraindicated — methotrexate and acitretin in particular, with acitretin requiring pregnancy avoidance for years after stopping. Tell the clinic about pregnancy plans before starting anything, not after.
Not a treatment plan sold on the spot. Message the clinic and bring your history.